ADAR1 Capital Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $510K | Buy |
34,051
+19,018
| +127% | +$285K | 0.08% | 112 |
|
|
2025
Q1 | $243K | Buy |
+15,033
| New | +$243K | 0.05% | 134 |
|
|
2024
Q4 | – | Sell |
-12,560
| Closed | -$369K | – | 274 |
|
|
2024
Q3 | $369K | Sell |
12,560
-22,620
| -64% | -$665K | 0.06% | 124 |
|
|
2024
Q2 | $827K | Sell |
35,180
-14,320
| -29% | -$337K | 0.16% | 69 |
|
|
2024
Q1 | $1.88M | Buy |
49,500
+43,060
| +669% | +$1.63M | 0.43% | 42 |
|
|
2023
Q4 | $139K | Buy |
+6,440
| New | +$139K | 0.05% | 80 |
|